News

Toprol-XL is an extended-release tablet that belongs to a family of high blood pressure medications dubbed beta-blockers. It is indicated for control of hypertension, angina, and heart failure.

The regulator issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for sarilumab, an investigational interleukin-6 receptor (IL-6R) antibody for the treatment of adult patients

Soft Tissue Sarcoma (STS) affects approximately 2.8 in 10,000 people in the EU and a recent statistic estimated 5-year survival rate of 58 % for patients suffering from

PharmaMar submitted the above mentioned application for the antitumor drug of marine origin, Aplidin, in combination with dexamethasone given the positive results obtained from the ADMYRE study. Plitidepsin

Study 311 is a global multicenter, single-arm Phase III clinical study of perampanel in approximately 160 patients (ages 4 to less than 12 years) with inadequately controlled partial-onset

Located in Mainz, Ganymed was established in 2001. It is engaged in the development of a new class of immunotherapeutic cancer drugs called ideal monoclonal antibodies (IMABs). The

Motus is a subsidiary of Rhythm Holding, which also owns Rhythm Pharmaceuticals. The acquisition will include Motus’ lead drug candidate relamorelin (RM-131), a ghrelin agonist being developed for

Investors participating in the round included VI Partners via the Venture Incubator fund and Zürcher Kantonalbank. The proceeds will be used to progress a drug candidate from Inositec’s

The study met its primary endpoint in this cohort as measured by a change in total chloride response following 4 weeks of treatment with QR-010. In the compound